SAN ANTONIO -- Patients with overweight or obesity lost an average one-fifth of their body weight with the highest dose of ...

Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ETCompany ParticipantsJustin Schreiber – Chairman and Chief ...

In return for his backing when Kennedy largely dropped his independent presidential bid, Trump has said he would allow Kennedy "to run wild" on healthcare, without offering details.

Q3 2024 Earnings Call Transcript November 6, 2024 WW International, Inc. misses on earnings expectations. Reported EPS is $-0 ...

Q3 2024 Earnings Call Transcript November 8, 2024 Operator: Ladies and gentlemen, good morning, and welcome to the Apyx ...

Good morning, and welcome to the Wave Life Sciences Third Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen only mode. As a reminder, this call is being ...

The Impact of New Weight Loss Drugs on Dietetics By Carrie Dennett, MPH, RDN Today’s Dietitian Vol. 26 No. 9 P. 14 What’s changed for weight-inclusive and weight management dietitians?

Analysts have set 12-month price targets for Novo Nordisk, revealing an average target of $159.43, a high estimate of $160.00 ...

Kantar, the world's leading marketing data and analytics company, today released its Who Cares Who Does: Decoding Wellness report on global wellness trends.

Within our life sciences vertical, we're seeing the investment in GLP-1 drugs as key pharma companies and their ... cost reduction actions we took earlier this year to align our cost structure with ...

As the FDA issues a new warning about aspiration across all GLP-1 weight loss drugs, doctor groups are giving new recommendations.

GLP-1 receptor agonists, originally developed for managing type 2 diabetes, have rapidly emerged as highly effective ...